- Home
- FHTX vs CDRO Comparison
FHTX vs CDRO Comparison
Compare FHTX & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FHTX | CDRO |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.2M | 363.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | FHTX | CDRO |
|---|---|---|
| Price | $5.78 | $8.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $11.71 | $8.50 |
| AVG Volume (30 Days) | ★ 111.3K | 6.9K |
| Earning Date | 04-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,602,000.00 | N/A |
| Revenue This Year | $40.87 | $11.31 |
| Revenue Next Year | $11.27 | $7.51 |
| P/E Ratio | ★ N/A | $305.95 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.94 | $5.18 |
| 52 Week High | $6.95 | $8.75 |
Technical Indicators
Market Signals| Indicator | FHTX | CDRO |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 52.64 |
| Support Level | $4.44 | $7.94 |
| Resistance Level | $5.85 | $8.23 |
| Average True Range (ATR) | 0.34 | 0.21 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 73.76 | 51.05 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.